Importance of hypoxia in the biology and treatment... (2002 study) Skip to main content
Clinical Study Neuroimaging clinics of North America 2002

Importance of hypoxia in the biology and treatment of brain tumors.

Knisely JP, Rockwell S, Neuroimaging clinics of North America, 2002

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors wrote a review of how low oxygen levels (hypoxia) in brain tumors may make them resistant to radiation and anticancer drugs, and of past attempts to get around that resistance.

What They Found

This review article states that brain tumors contain extensive regions of severe hypoxia, that hypoxic cells are resistant to radiation, and that this may contribute to treatment resistance in gliomas, while no approach tried so far has produced a significant, reproducible improvement in outcomes. Hypoxia also produces resistance to many commonly used anticancer drugs. The authors note that laboratory studies suggest hypoxia may drive changes in gene expression and mutations, and may be involved in low-grade tumors becoming aggressive glioblastomas. Over 50 years, attempts to overcome hypoxia included improving tumor oxygenation, oxygen-mimetic radiosensitizers, drugs toxic to hypoxic cells, hyperthermia, and radiation regimens less affected by hypoxia. Past clinical trials gave "tantalizing suggestions" of benefit, but none has yet shown a significant, reproducible improvement.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a narrative review rather than a new trial, so it reports no new patient data, and some of its points about hypoxia and tumor evolution come from laboratory studies rather than human trials.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Radiation Injury
Source Pubmed
PubMed ID 12687909
Year Published 2002
Journal Neuroimaging clinics of North America
MeSH Terms Animals; Brain Neoplasms; Cell Hypoxia; Combined Modality Therapy; Drug Resistance, Neoplasm; Glioma; Humans; Hyperbaric Oxygenation; Oxygen; Radiation Tolerance; Radiation-Sensitizing Agents

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology